A team of scientists at the University of North Carolina at Chapel Hill, North Carolina Central University, and the Hamner Institutes for Health Sciences will be working with the National Cancer Institute as part of a national effort to bring … Read more
One of the most challenging situations that oncologists face is when chemotherapy fails to slow down or stop the growth of cancer. This phenomenon, called multi-drug resistance, is the result of several simultaneous biochemical processes that scientists do not fully … Read more
Eric Butter, a junior at the University of North Carolina at Chapel Hill, was selected by the National Institute of Allergy and Infectious Diseases to attend a workshop for academically talented, undergraduate and graduate students performing research in allergy, immunology, … Read more
Application of nanotechnology to cancer, siRNA delivery, infectious diseases and vaccines, imaging and diagnostics, as well as nanomaterials engineering and nanotoxicology will be the topics of this year’s Chapel Hill Drug Conference at the University of North Carolina at Chapel … Read more
Russell Mumper, PhD, an internationally recognized leader in the pharmaceutical applications of nanotechnology, has joined the UNC School of Pharmacy as the John A. McNeill Distinguished Professor. Mumper, an expert in vaccine and cancer drug delivery systems, will serve as … Read more
